| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.2M | -35.5% |
| Cost of Revenue | $10.1M | -34.1% |
| Gross Profit | $6.1M | -37.6% |
| R&D Expense | $4.4M | -53.2% |
| SG&A Expense | $8.7M | -14.9% |
| Operating Income | -$16.8M | +49.0% |
| Pre-tax Income | -$16.5M | +46.2% |
| Income Tax | $161K | +151.4% |
| Net Income | -$16.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -82.8% |
| Accounts Receivable | $3.8M | -54.6% |
| Current Assets | $5.8M | -65.7% |
| Total Assets | $11.7M | -53.8% |
| Current Liabilities | $10.4M | -21.9% |
| Total Liabilities | $11.5M | -24.8% |
| Stockholders' Equity | $170K | -98.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.5M | +26.0% |
| Capital Expenditures | $23K | +187.5% |
| Investing Cash Flow | -$283K | +65.7% |
| Financing Cash Flow | $5.4M | -74.6% |
| Free Cash Flow | -$11.5M | +25.9% |
| +45.2% |
| EPS (Basic) | -$2.35 | +82.8% |